GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Braemar Hotels & Resorts Inc (NYSE:BHR) » Definitions » Research & Development

BHR (Braemar Hotels & Resorts) Research & Development : $0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Braemar Hotels & Resorts Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Braemar Hotels & Resorts's Research & Development for the three months ended in Sep. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0.0 Mil.


Braemar Hotels & Resorts Research & Development Historical Data

The historical data trend for Braemar Hotels & Resorts's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braemar Hotels & Resorts Research & Development Chart

Braemar Hotels & Resorts Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Braemar Hotels & Resorts Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Braemar Hotels & Resorts Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Braemar Hotels & Resorts  (NYSE:BHR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Braemar Hotels & Resorts Research & Development Related Terms

Thank you for viewing the detailed overview of Braemar Hotels & Resorts's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Braemar Hotels & Resorts Business Description

Traded in Other Exchanges
Address
14185 Dallas Parkway, Suite 1200, Dallas, TX, USA, 75254
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and Renaissance, among others.
Executives
Abteen Vaziri director 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Richard J Stockton officer: Chief Executive Officer 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Montgomery J Bennett director, officer: Chief Executive Officer 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Mary Candace Evans director 11407 WEST RICKS CIRCLE, DALLAS TX 75230
Rebeca M Johnson director 14185 DALLAS PARKWAY, SUITE 1200, DALLAS TX 75240
Curtis B Mcwilliams director 450 SOUTH ORANGE AVENUE, ORLANDO FL 32801
Alex Rose officer: Exec. VP, GC and Secretary 14185 DALLAS PARKWAY, SUITE 1200, DALLAS TX 75254
Deric S Eubanks officer: CFO and Treasurer 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Stefani D Carter director 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Mark Nunneley officer: Chief Accounting Officer 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Robert G. Haiman officer: Exec. VP, GC and Secretary 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Jeremy Welter officer: EVP-Asset Management 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Darrouzet Sarah Zubiate director 14185 DALLAS PARKWAY, SUITE 1100, DALLAS TX 75254
Daniel B. Silvers director 1199 PARK AVENUE #17A, NEW YORK NY 10128
Lawrence A Cunningham director 4521 HIGHWOODS PARKWAY, GLEN ALLEN VA 23060